Turklingua

Mastering Turkish HEOR Data for Market Access

Navigating the complexities of Turkish healthcare outcomes with unrivaled translation precision and three decades of specialized life science expertise

ISPOR-aligned linguistic validationSubject-matter expert Turkish linguists30+ years of medical research experience

Request a Professional HEOR Translation Quote

Health Outcomes Research

Can your patient outcomes survive a flawed Turkish linguistic validation process?

Inaccurate patient-reported outcomes translations risk regulatory rejection and clinical trial failure while compromising your global data integrity

Regulatory Risk

Errors in Turkish Value Dossiers can lead to immediate rejection by local health authorities and reimbursement delays

Data Validity

Improperly localized PROMs yield skewed statistical results, ruining the scientific credibility of your outcomes research

Market Entry

Failing to meet Turkish linguistic standards prevents successful market access and costs millions in lost revenue

Comprehensive HEOR Documentation Support

From PROs to economic models, we cover all your Turkish HEOR documentation needs

Patient-Reported Outcome Measures
Quality of Life Questionnaires
Global Value Dossiers
Health Economic Models
Budget Impact Analyses
Cost-Effectiveness Reports
Linguistic Validation Certificates
Cognitive Debriefing Reports
Patient Recruitment Materials
Clinician-Reported Outcomes
Systematic Literature Reviews
Regulatory Submission Files
Reimbursement Applications
Epidemiological Study Data
Meta-Analysis Summaries
Patient Information Leaflets
Informed Consent Forms
Clinical Trial Protocols
HTA Submission Packages
Real-World Evidence Reports
Health Outcomes Research Expertise

Unmatched Proficiency in Turkish Health Outcomes

Master the Turkish HEOR landscape with our subject-matter expert translators

Our approach to Health Economics and Outcomes Research translation goes far beyond literal word substitution. We understand that in the Turkish market, cultural nuances and regulatory terminology are paramount to project success. We employ only those linguists who possess deep background knowledge in life sciences and health economics to ensure every data point is accurate.

At Turklingua, we strictly follow ISPOR guidelines for the linguistic validation of Patient-Reported Outcomes (PROs). This rigorous process ensures that the Turkish version of your instrument is psychometrically equivalent to the original, allowing for seamless data pooling across global sites without the risk of linguistic bias or misunderstanding by Turkish patients.

Precision is our core value when handling Health Technology Assessment (HTA) submissions. We ensure that your Value Dossiers and budget impact models are translated with absolute technical fidelity, making your clinical evidence compelling to Turkish payers and decision-makers who demand high-caliber, localized documentation for reimbursement approvals.

The Gold Standard for Turkish Research Translation

Three decades of specialized expertise in Turkish medical and economic linguistic services

With over thirty years of experience, Turklingua has established itself as the preeminent provider of high-stakes Turkish medical translations, supporting global pharmaceutical leaders through complex HEOR cycles.

We utilize Subject-Matter Experts who are not just translators, but specialists in health economics, ensuring that your economic modeling data remains statistically sound in Turkish.

Our ISO-aligned quality assurance protocols guarantee that every linguistic validation project meets the highest global standards, providing you with total confidence in your Turkish market access strategy.

Our HEOR Translation Protocol

The Turklingua method for flawless Turkish health economics and outcomes translation

01

Strategic Project Initiation

We begin by analyzing your HEOR assets and defining the specific linguistic validation requirements needed for the Turkish regulatory landscape

02

Dual Forward Translation

Two independent Turkish medical translators create forward versions to capture conceptual equivalence rather than just literal meaning

03

Linguistic Harmonization

A third senior reviewer reconciles the translations into a unified Turkish version, ensuring optimal clarity and flow for target respondents

04

Blind Back Translation

An independent linguist translates the document back into the source language to verify accuracy and identify any potential conceptual shifts

05

Cognitive Debriefing Support

We assist in testing the Turkish instrument with target patient groups to ensure comprehension and refine the linguistic nuances

06

Final Quality Certification

Our QA team performs a final multi-layer review before issuing a formal certificate of linguistic validation for your submission

Addressing your concerns about Turkish linguistic validation and outcomes research

HEOR Strategic Clarifications

Do you follow ISPOR guidelines for Turkish linguistic validation?

Yes, we strictly adhere to ISPOR Principles of Good Practice. Our process involves dual forward translation, harmonization, and back-translation to ensure your Turkish PROMs are conceptually equivalent to the original source and ready for regulatory scrutiny.

Can you handle complex economic models and budget impact analyses?

Absolutely. Our translators are subject-matter experts in health economics. We ensure that the technical terminology in your budget impact models and cost-effectiveness reports is translated with absolute precision for Turkish payers and HTA bodies.

How do you ensure the privacy of sensitive clinical data?

Data security is our priority. We employ bank-grade encryption and strict confidentiality agreements. All Turkish HEOR projects are handled within a secure environment, ensuring your proprietary research and patient data remain fully protected throughout the process.

What is the typical turnaround for a linguistic validation project?

Timeline varies based on complexity, but a standard linguistic validation usually takes 2 to 3 weeks. This includes multi-stage reviews and harmonization to guarantee that the Turkish version is psychometrically sound and culturally appropriate.

Do you provide certificates of accuracy for regulatory submissions?

Yes, we provide formal Certificates of Linguistic Validation. These documents are essential for submissions to the Turkish Medicines and Medical Devices Agency (TITCK) and other global regulatory bodies, confirming our rigorous quality control.

Are your translators native Turkish speakers with medical backgrounds?

Every linguist on our HEOR team is a native Turkish speaker with an advanced degree in medicine, pharmacy, or health economics. This ensure they understand the scientific context of your outcomes research, not just the language.

How do you handle patient-reported outcomes for children or elderly?

We apply age-appropriate linguistic adaptation. Our team ensures the Turkish terminology is accessible to the specific target demographic, maintaining the instrument's validity while ensuring patients can easily understand and answer the questions.

Can you localize digital HEOR platforms and mobile health apps?

Yes, we specialize in SaaS and Mobile App localization for the healthcare sector. We ensure your digital HEOR interfaces are fully functional and linguistically optimized for the Turkish user experience and technical requirements.

Trusted by Global Leaders in Outcomes Research

Real-world success stories from the most demanding HEOR projects worldwide

Turklingua's linguistic validation of our oncology PROMs was flawless. Their deep Turkish regulatory knowledge saved us months of rework.

Head of Global Market Access

Pharmaceuticals

Basel, Switzerland

For Turkish market entry, they are the only partner we trust. Their subject-matter expertise in health economics is truly unrivaled.

Senior HEOR Director

Contract Research Organization

Durham, NC, USA

The precision and speed of their Turkish value dossier translations were instrumental in our successful reimbursement negotiation.

Lead Clinical Outcomes Researcher

Biotechnology

Cambridge, UK

Partnering with the World's Preeminent Life Science Organizations

Pfizer
Novartis
Roche
IQVIA
AstraZeneca
Sanofi